Jun
30
2018
Highlights |
Einstein and Montefiore Awarded $25 Million from the NIH to Continue its Institute for Clinical and Translational Research
Albert Einstein College of Medicine and Montefiore Health System have received $25 million from the National Institutes of Health (NIH), to continue support for the Block Institute for Clinical and Translational Research (ICTR). The new grant marks the third, five-year Clinical and Translational Science Award (CTSA) that the ICTR has received to support its mission to accelerate the translation of research discoveries into improved health care. Take a closer look.
|
Zucker School of Medicine at Hofstra Northwell: Blood Markers Identify Lupus Risk
Zucker School of Medicine at Hofstra/Northwell professor of molecular medicine, Betty Diamond, MD, and colleagues at the Feinstein Institute for Medical Research discovered what they believe can identify a person’s risk for lupus by looking at the presence and amount of antibodies and a protein complex in blood. Take a closer look.
|
Neurology |
Icahn School of Medicine at Mount Sinai: Human Drug Addiction Behaviors Closely Tied to Specific Impairments Within Six Large-Scale Brain Networks
Specific impairments within six large-scale brain networks during drug cue exposure, decision-making, inhibitory control, and social-emotional processing are associated with drug addiction behaviors, according to a systematic review of more than 100 published neuroimaging studies by experts at the Icahn School of Medicine at Mount Sinai and published in the journal Neuron. Take a closer look.
|
NYU School of Medicine: Cannabidiol Significantly Reduces Seizures in Patients With Severe Form of Epilepsy
Cannabidiol (CBD), a compound derived from the cannabis plant that does not produce a “high” and has been an increasing focus of medical research, was shown in a new large-scale, randomized, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox-Gastaut syndrome. Take a closer look.
|
Icahn School of Medicine at Mount Sinai: Zinc and Copper Metabolic Cycles in Baby Teeth Linked to Autism
Using evidence found in baby teeth, researchers from the Institute for Exposomic Research at the Icahn School of Medicine at Mount Sinai report that cycles involved in zinc and copper metabolism are dysregulated in autism spectrum disorder (ASD), and can be used to predict who will later develop the disease. Take a closer look.
|
Other Studies |
Weill Cornell Medicine: Study of Nanoparticles Points to New Imaging Technologies
Tiny carrier molecules called nanoparticles are often attached to radiation-emitting atoms in advanced medical imaging systems such as positron emission tomography (PET). These nanoparticles, paired with the right radioactive partners, can emit their own distinctive and readily detectable radiation-often visible light, according to a study from Weill Cornell Medicine scientists. Take a closer look.
|
NYU School of Medicine Researchers Find Autism Screening App is Caregiver-Friendly & Produces Reliable Scientific Data
A study of an iPhone app used to screen young children for signs of autism shows that the app is a novel, easy to use, and scalable method for collecting high-quality and scientifically valid data, according to a new study published June 1 in the journal npj Digital Medicine. Take a closer look.
|
Weill Cornell Medicine: Most Platelet Transfusions in Critically Ill Children Given to Prevent Bleeding
Two thirds of children in the pediatric intensive care unit (PICU) who receive transfusions of platelets-a component of the blood that helps it to clot-do so to prevent bleeding, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian investigators. The other third of patients receive the transfusions to stop active bleeding. Take a closer look.
|
Other News |
New York Medical College: Department of Family and Community Medicine Hosts Sixth Annual Research Day
The Department of Family and Community Medicine hosted its Sixth Annual Research Day on May 9 to highlight the scholarly research of students, residents and faculty. Take a closer look.
|
Opioid-Free Surgeries Now Offered for Some Procedures at Albany Med
Patients undergoing a select number of surgeries at Albany Med are experiencing improved recoveries, shorter hospital stays, and better pain management with less need for opioids for pain, thanks to a new, multi-disciplinary approach to surgical care. Take a closer look.
|